Corticosteroids in ophthalmic herpes
Kaplunovich, P.S.
Vestnik Oftalmologii 3: 69-70
1980
ISSN/ISBN: 0042-465X PMID: 7404949 Document Number: 164333
Document emailed within 1 workday
Related Documents
Giacovazzo, M.; Di Sabato, F.; Gallo, M.F.; Granata, M.; Martelletti, P. 1992: "Chronic paroxysmal hemicrania" following ophthalmic herpes zoster Rivista Europea Per le Scienze Mediche e Farmacologiche 14(1): 45-47Mal'khanov, V.B.; Gripas', I.A.; Kurenkova, T.N. 1983: Laboratory diagnosis of chronic forms of ophthalmic herpes Voprosy Virusologii 28(6): 684-686
Papeix, C.; Dumurgier, J.; Miléa, D.; Pierrot, D.C. 2005: Complete ophthalmoplegia complicating ophthalmic herpes zoster Revue Neurologique (Paris) 161(5): 590-592
Shchipanova, A.I.; Petrishcheva, G.S.; Maichuk, I.F.; Fridman, F.E. 1983: Pharmacokinetic evaluation of idoxuridine phonophoresis in ophthalmic herpes in the rabbit Oftalmologicheskii Zhurnal 7: 395-396
Pönnighaus, J.M.; Ziegler, H.; Kowalzick, L. 1998: Herpes gestationis--oral corticosteroids cannot be avoided Zentralblatt für Gynakologie 120(11): 548-550
Zhang, J.M.; Lin, P.F.; Chen, L.L.; Tang, L.H.; Hong, X.Q.; Liang, B.X.; Chen, H.S.; Teng, L. 1993: Efficacy of xiaoxingzhang guttae ophthalmic eye drops in the treatment of experimental herpes simplex keratitis Zhongguo Zhong Yao Za Zhi 18(1): 49-52; 64
Homer, J.J.; England, R.J.; Ell, S.R. 1998: Steroids in facial palsy due to herpes zoster. Corticosteroids are accepted treatment Bmj 316(7126): 234
Kasavina, B.S.; Maĭchuk, I.F.; Dalgat, L.D.; Romashchenko, A.D. 1982: Effect of the water-soluble antioxidant hydroxypyridine-6 on the intensity of lipid peroxidation in eye tissues in experimental ophthalmic herpes Biulleten' Eksperimental'noi Biologii i Meditsiny 94(7): 27-28
L'vov, N.D.; Samoĭlovich, E.O.; Tikhonchuk, I.A.; Chepaĭkina, T.A.; Tsvetkov, E.N. 1989: Antiherpetic activity of Soviet-made phosphonic acid derivatives and their combinations with interferon inducers in a model of ophthalmic herpes Voprosy Virusologii 34(2): 186-192
Meylan, P. 2005: Recommandations suisses pour le traitement de l'herpès génital et de l'herpès du nouveau-né - Swiss recommendations for the management of genital herpes and herpes simplex virus infection of the neonate Revue Medicale Suisse 1(36): 2315-2326
Allen, L.V. 2016: Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions International Journal of Pharmaceutical Compounding 20(5): 399-404
Berggren, L.; Renström, A. 1978: Extempore prepared ophthalmic solutions and ophthalmic ointments Lakartidningen 75(3): 137-140
Mashkilleyson, N.; Mashkilleyson, A.L. 1988: Mucous membrane manifestations of pemphigus vulgaris. A 25-year survey of 185 patients treated with corticosteroids or with combination of corticosteroids with methotrexate or heparin Acta Dermato-Venereologica 68(5): 413-421
Wittels, W. 1971: Antibiotics and corticosteroids in the corticosteroids in the treatment of burns Wiener Klinische Wochenschrift 83(52): 936-938
Kawai, M. 1982: Corticosteroids (drug evaluation of corticosteroids) Nihon Kyobu Shikkan Gakkai Zasshi 20(11): 1144-1155
Spangler, D.L.; Bensch, G.; Berdy, G.J. 2001: Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model Clinical Therapeutics 23(8): 1272-1280
Arase, S.; Nagai, R.; Nakanishi, H.; Takeda, K. 1988: Effects of six topical corticosteroids on DNA synthesis of normal human skin fibroblasts--in vitro evaluation of anti-proliferative possibly anti-inflammatory potencies of corticosteroids Tokushima Journal of Experimental Medicine 35(1-2): 1-4
Vestergaard, B.F. 1982: A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes Developments in Biological Standardization 52: 95-98
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174